随机的DIALIZE-Outcomes试验评估了在血液透析中的氧化环酸盐
Steven Fishbane1, Laura M Dember2, Michel Jadoul3
1Division of Nephrology, Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.
Kidney international
|July 6, 2025
概括
氧化环酸盐 (SZC) 没有降低血液透析患者的心血管事件,尽管有效控制血清水平. 需要进一步的研究来澄清其在治疗病并发症中的作用.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 临床试验 临床试验
背景情况:
- 维护血液透析患者经常患有透析前高胆血症,心律失常和心血管风险增加.
- 在DIALIZE-Outcomes试验中,研究了环环酸盐 (SZC) 对于这些结果.
研究的目的:
- 评估氧化环酸盐 (SZC) 在降低血液透析患者心律失常相关心血管事件的疗效.
- 评估SZC对血清控制和整体心血管安全的影响.
主要方法:
- 成年血液透析患者患有高血症 (血清≥5.5 mmol/l) 被随机分配到SZC或安慰剂中.
- 主要终点是突发心脏病死亡,中风或心律失常相关住院治疗/干预的复合结果.
- SZC的剂量每周定位一次,以达到正常血量 (4.0-5.0 mmol/l).
主要成果:
- 该试验因低事件率和高停药率而提前终止.
- SZC对初级复合心血管终点没有显著影响 (HR 0.98;95% CI 0.76-1.26).
- SZC显著改善了正常血维持率 (74.0%与47.0%相比;OR3.36),但低血的比率较高 (3.0%与1.4%相比).
结论:
- 环环酸盐 (SZC) 在这个人群中没有证明对心律失常相关心血管结果有好处.
- 尽管SZC在血清度正常化中的有效性,但SZC在预防主要心血管事件的临床效用仍然没有得到证实.
更多相关视频
07:13High Temperature Fabrication of Nanostructured Yttria-Stabilized-Zirconia YSZ Scaffolds by In Situ Carbon Templating Xerogels
Published on: April 16, 2017
10.9K
11:14Two-way Valorization of Blast Furnace Slag: Synthesis of Precipitated Calcium Carbonate and Zeolitic Heavy Metal Adsorbent
Published on: February 21, 2017
12.5K
相关概念视频
01:24Hemodialysis II: Procedure and Complications
143
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
143
01:15Dialysis
821
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
821
01:25Hemodialysis I: Introduction
310
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
310
01:25Hemodialysis III: Nursing Management
196
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
196
01:30Continuous Renal Replacement Therapy
155
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
155
01:20Acute Kidney Injury V: Interprofessional Care
48
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
48